Feasibility and acceptance of transdermal auricular vagus nerve stimulation using a TENS device in females suffering from LC fatigue 2025 Crevenna+

Discussion in 'Long Covid research' started by Andy, Feb 21, 2025.

  1. Andy

    Andy Retired committee member

    Messages:
    23,559
    Location:
    Hampshire, UK
    Summary

    Background
    The COVID-19 pandemic has led to significant health challenges, with some individuals developing long COVID characterized by persistent symptoms such as fatigue, dyspnea and cognitive difficulties lasting weeks or months after infection. This condition predominantly affects women and may involve prolonged inflammation and autonomic nervous system dysfunction. Current treatments focus on symptom relief and vagus nerve stimulation (VNS) is being investigated for its potential therapeutic benefits.

    Methods
    This pilot study was a prospective, blinded, randomized controlled trial involving 36 female long COVID patients aged 18–70 years. Participants were assigned to three groups receiving VNS at frequencies of 10 Hz, 25 Hz, or a control of 2 Hz for 3 months. Outcomes were assessed at baseline, after 4 and 12 weeks.

    Results
    The study revealed that all VNS treatment groups experienced reduction in symptoms associated with long COVID, particularly in fatigue and dyspnea, after 12 weeks. Participants across all frequencies reported an improvement in health-related quality of life. Heart rate variability remained stable throughout the trial, and no significant changes in morning salivary cortisol levels were seen across groups.

    Discussion
    Vagus nerve stimulation may offer therapeutic benefits for women with long COVID, particularly in reducing fatigue and dyspnea. The treatment was found to be safe, with no significant side effects reported; however, further research with larger study groups is needed to confirm these findings and examine the long-term effects of VNS on autonomic nervous system function.

    Open access
     
    Peter Trewhitt likes this.
  2. Yann04

    Yann04 Senior Member (Voting Rights)

    Messages:
    1,700
    Location:
    Romandie (Switzerland)
    To me this is a sign that the effect is placebo. If it was a medical effect there would likely be some strengths and frequencies where it works and some where it doesn’t, right?

    Because the difference between 2Hz and 25Hz is more than tenfold!
     
  3. Yann04

    Yann04 Senior Member (Voting Rights)

    Messages:
    1,700
    Location:
    Romandie (Switzerland)
    I’ll also say as someone who has tried the VA-TNS I have noticed no symptomatic differences except perhaps a reduction in the “wired” feeling.
     
    alktipping and Peter Trewhitt like this.
  4. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    1,142
    Location:
    Norway
    There is no mention of clinical significance for any of the scales used. And no p-values or any other statistics. No real placebo because 2 hz is still a treatment. They essentially just say that the self-reported numbers changed some.
     

Share This Page